TAS1R3: A Promising Drug Target and Biomarker for Pain Management

Target Name: TAS1R3

NCBI ID: G83756

TAS1R3

TAS1R3: A Promising Drug Target and Biomarker for Pain Management

Introduction

Pain is a universal human experience that affects millions of individuals worldwide. The World Health Organization (WHO) estimates that approximately 50% of the global population experiences chronic pain, with the majority of cases being caused by non-communicable diseases such as musculoskeletal, neuropathic , and psychiatric conditions. Chronic pain can significantly impact a person's quality of life, leading to functional limitations, disability, and even depression. As such, the development of effective pain modalities and strategies for its management have become a priority in the pharmaceutical and clinical industries.

TAS1R3, a protein expressed in the endoplasmic reticulum (ER), was identified as a potential drug target and biomarker for pain management. Its function in cell signaling and its expression in various tissues make it an attractive target for pharmacological intervention. This article will provide an overview of TAS1R3, its potential as a drug target and biomarker, and its current research status.

The Endoplasmic Reticulum and TAS1R3

The endoplasmic reticulum (ER) is a membrane-bound system that functions as a transporter for various proteins, including TAS1R3. It is a complex organelle that spans the entire length of the cell and is involved in the delivery and processing of proteins from the cytoplasm to the ER. The ER is a crucial organelle for the biosynthesis, storage, and folding of proteins, and it is also involved in the regulation of various cellular processes, including protein folding, localization, and degradation.

TAS1R3 is a member of the TAS1R family, which includes four structurally similar proteins: TAS1R2, TAS1R3A, TAS1R3B, and TAS1R4. These proteins share a conserved catalytic core and are characterized by their ability to transfer a phosphate group to small molecules, such as ion channels, G-protein-coupled receptors (GPCRs), and protein tyrosylated enzymes (PTEs). TAS1R3 is unique in that it has a unique N-terminus, which is involved in its protein-protein interactions and localization in the ER.

TAS1R3's Localization and Interaction

TAS1R3 is predominantly expressed in the ER, where it is involved in various cellular processes, including protein folding, localization, and degradation. The ER is a complex organelle that spans the entire length of the cell and is involved in the biosynthesis, storage, and folding of proteins. As such, TAS1R3 is primarily localized to the ER, where it plays a critical role in the regulation of protein function and localization.

TAS1R3 has been shown to interact with various protein partners, including other TAS1R family members, GPCRs, and PTEs. These interactions are critical for TAS1R3's localization and stability in the ER. TAS1R3 has been shown to form a complex with the protein co-expression partner , p120GAP, which is involved in the regulation of protein-protein interactions and localization in the ER.

TAS1R3's Potential as a Drug Target

TAS1R3's unique localization and interaction in the ER make it an attractive drug target for the development of pain modalities. The TAS1R3-p120GAP complex has been shown to play a critical role in the regulation of pain signaling, and pharmacological intervention has been shown to modulate TAS1R3 -p120GAP interactions in the ER.

TAS1R3 has been shown to play a critical role in the regulation of pain perception and neuroinflammation. Chronic pain is associated with an increased risk of neuroinflammation, which can contribute to the development and maintenance of chronic pain. TAS1R3 has been shown to be involved in the regulation of neuroinflammation by modulating the activity

Protein Name: Taste 1 Receptor Member 3

Functions: Putative taste receptor. TAS1R1/TAS1R3 responds to the umami taste stimulus (the taste of monosodium glutamate). TAS1R2/TAS1R3 recognizes diverse natural and synthetic sweeteners. TAS1R3 is essential for the recognition and response to the disaccharide trehalose (By similarity). Sequence differences within and between species can significantly influence the selectivity and specificity of taste responses

The "TAS1R3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAS1R3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets